A topological modification of ipriflavone 1, a recent anti-osteoporoti
c drug, is described. The flavone moiety of 1 has been replaced by a x
anthone one. Among the new derivatives, the 3,6-diisopropoxyxanthone (
2a) has shown significant bone resorption inhibition in in vitro and i
n vivo tests.